124 related articles for article (PubMed ID: 24343338)
21. Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility.
Salinas-Sánchez AS; Donate-Moreno MJ; López-Garrido MP; Giménez-Bachs JM; Escribano J
J Urol; 2012 Feb; 187(2):700-6. PubMed ID: 22177211
[TBL] [Abstract][Full Text] [Related]
22. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck.
Li G; Liu Z; Sturgis EM; Chamberlain RM; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1034-6. PubMed ID: 15824189
[No Abstract] [Full Text] [Related]
23. Polymorphism in cytochrome P450 2A6 and glutathione S-transferase P1 modifies head and neck cancer risk and treatment outcome.
Ruwali M; Pant MC; Shah PP; Mishra BN; Parmar D
Mutat Res; 2009 Oct; 669(1-2):36-41. PubMed ID: 19406142
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
25. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
26. CYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.
Mei Q; Zhou D; Han J; Lu H; Tang B
Metabolism; 2012 Sep; 61(9):1321-9. PubMed ID: 22459615
[TBL] [Abstract][Full Text] [Related]
27. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.
Sillanpää P; Heikinheimo L; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Metsola K; Hirvonen A
Breast Cancer Res Treat; 2007 Sep; 104(3):287-97. PubMed ID: 17063266
[TBL] [Abstract][Full Text] [Related]
28. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
Chen PF; He XF; Huang GH; Wang W; Qiu ZH
Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
[TBL] [Abstract][Full Text] [Related]
29. Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.
Liu JY; Yang Y; Liu ZZ; Xie JJ; Du YP; Wang W
Mol Genet Genomics; 2015 Apr; 290(2):739-65. PubMed ID: 25475389
[TBL] [Abstract][Full Text] [Related]
30. Effects of potentially functional polymorphisms in suppressor of cytokine signaling 3 (SOCS3) on the risk of head and neck squamous cancer.
Hang D; Yin Y; Wang L; Yuan H; Du J; Zhu M; Dai J; Chen N; Hu Z; Shen H; Ma H
J Oral Pathol Med; 2017 Sep; 46(8):598-602. PubMed ID: 27977878
[TBL] [Abstract][Full Text] [Related]
31. Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study.
Ickstadt K; Schäfer M; Fritsch A; Schwender H; Abel J; Bolt HM; Brüning T; Ko YD; Vetter H; Harth V
J Toxicol Environ Health A; 2008; 71(11-12):803-15. PubMed ID: 18569579
[TBL] [Abstract][Full Text] [Related]
32. Association between a miRNA-146a polymorphism and susceptibility to head and neck squamous cell carcinoma in Chinese patients: A meta-analysis of 8 case-control studies.
Zhang S; Hu F; Liang H; Liu Y; Yang J; Zhou W
PLoS One; 2017; 12(10):e0186609. PubMed ID: 29049342
[TBL] [Abstract][Full Text] [Related]
33. Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review.
Paracchini V; Raimondi S; Gram IT; Kang D; Kocabas NA; Kristensen VN; Li D; Parl FF; Rylander-Rudqvist T; Soucek P; Zheng W; Wedren S; Taioli E
Am J Epidemiol; 2007 Jan; 165(2):115-25. PubMed ID: 17053044
[TBL] [Abstract][Full Text] [Related]
34. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer.
Watanabe J; Shimada T; Gillam EM; Ikuta T; Suemasu K; Higashi Y; Gotoh O; Kawajiri K
Pharmacogenetics; 2000 Feb; 10(1):25-33. PubMed ID: 10739169
[TBL] [Abstract][Full Text] [Related]
35. Leu432Val Polymorphism of CYP1B1 is Not Associated with Squamous Cell Carcinoma of Esophagus--a Case-Control Study from Kashmir, India.
Shah IA; Mehta P; Lone MM; Dar NA
Asian Pac J Cancer Prev; 2015; 16(13):5337-41. PubMed ID: 26225675
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: evidence for gene-gene and gene-environment interaction.
Maurya SS; Anand G; Dhawan A; Khan AJ; Jain SK; Pant MC; Parmar D
Environ Mol Mutagen; 2014 Mar; 55(2):134-44. PubMed ID: 24519899
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2-1195G>A Polymorphism and Head and Neck Squamous Cell Carcinoma Susceptibility: A Meta-Analysis of 1564 Cases and 2346 Controls.
Deng DL; Xia LY; He BY; Guo JM; Huang C; Zeng XT
Med Sci Monit; 2015 Nov; 21():3514-20. PubMed ID: 26568042
[TBL] [Abstract][Full Text] [Related]
38. Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk.
Wang JR; Gramling SJ; Goldstein DP; Cheng D; Chen D; Azad AK; Tse A; Hon H; Chen Z; Mirshams M; Simpson C; Huang SH; Marquez S; O'Sullivan B; Liu FF; Roberts H; Xu W; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Reisman DN; Liu G
Carcinogenesis; 2013 May; 34(5):1012-7. PubMed ID: 23322154
[TBL] [Abstract][Full Text] [Related]
39. Estrogen and cytochrome P450 1B1 contribute to both early- and late-stage head and neck carcinogenesis.
Shatalova EG; Klein-Szanto AJ; Devarajan K; Cukierman E; Clapper ML
Cancer Prev Res (Phila); 2011 Jan; 4(1):107-15. PubMed ID: 21205741
[TBL] [Abstract][Full Text] [Related]
40. Interaction between genetic polymorphism of cytochrome P450-1B1 and environmental pollutants in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Eur J Cancer Prev; 2004 Feb; 13(1):83-6. PubMed ID: 15075793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
